| Year |
Citation |
Score |
| 2019 |
Clarke SR, Naccara AH, Loya AJ, Marchant SW, Wang X, LaJoie TJ, Smith JN, Rice KP. Abstract 266: Relationship between BAG3 expression and the cytotoxicity of laromustine in HL60 cells Cancer Research. 79: 266-266. DOI: 10.1158/1538-7445.Am2019-266 |
0.374 |
|
| 2017 |
Loya AJ, Cincotta DJ, Elkahloun A, Bodine D, Rice KP. Abstract 2109: Transcriptional analysis of human leukemia cells treated with the experimental anticancer drug laromustine Cancer Research. 77: 2109-2109. DOI: 10.1158/1538-7445.Am2017-2109 |
0.586 |
|
| 2016 |
Rice KP, Loya AJ, Gross KM. Abstract 4777: The role of BAG3 in human leukemia cells’ response to the experimental anticancer drug laromustine Cancer Research. 76: 4777-4777. DOI: 10.1158/1538-7445.Am2016-4777 |
0.599 |
|
| 2015 |
Plaskon D, Guerra RM, McGuckin CP, Ruiz VL, Sheehan CT, Weeks RA, Cincotta D, Rice KP. Abstract 2444: Directed evolution strategy for generating of novel zinc finger peptides with affinity for gapped DNA Cancer Research. 75: 2444-2444. DOI: 10.1158/1538-7445.Am2015-2444 |
0.48 |
|
| 2014 |
Ji W, Yang M, Praggastis A, Li Y, Zhou HJ, He Y, Ghazvinian R, Cincotta DJ, Rice KP, Min W. Carbamoylating activity associated with the activation of the antitumor agent laromustine inhibits angiogenesis by inducing ASK1-dependent endothelial cell death. Plos One. 9: e103224. PMID 25068797 DOI: 10.1371/Journal.Pone.0103224 |
0.477 |
|
| 2014 |
Robinson KN, Coe KA, Owumi JE, Rice KP. Abstract 5498: Changes in expression of DNA repair genes in human leukemia cells treated with laromustine Cancer Research. 74: 5498-5498. DOI: 10.1158/1538-7445.Am2014-5498 |
0.609 |
|
| 2013 |
Guerra RM, Langenborg KM, Gross KM, Sher EV, Gilboy JW, Plaskon D, Rice KP. Abstract 2236: A selection strategy for the design of small proteins that can distinguish DNA repair intermediates. Cancer Research. 73: 2236-2236. DOI: 10.1158/1538-7445.Am2013-2236 |
0.437 |
|
| 2012 |
Rice KP, Klinkerch EJ, Gerber SA, Schleicher TR, Kraus TJ, Buros CM. Thioredoxin reductase is inhibited by the carbamoylating activity of the anticancer sulfonylhydrazine drug laromustine. Molecular and Cellular Biochemistry. 370: 199-207. PMID 22864532 DOI: 10.1007/S11010-012-1411-Y |
0.486 |
|
| 2012 |
Kaye EG, Gross KM, Bellairs J, Dale LE, Gallagher C, Sher EV, Robinson KN, Rice KP. Abstract 1764: Changes in apoptotic gene expression in human leukemia cells treated with the anticancer drug Laromustine Cancer Research. 72: 1764-1764. DOI: 10.1158/1538-7445.Am2012-1764 |
0.607 |
|
| 2011 |
Ghazvinian R, Praggastis VA, Li X, Zhang W, Klinkerch EJ, Coleman CJ, Boches AT, Bellairs JA, Min W, Rice KP. Abstract 4469: Carbamoylating activity associated with the antitumor prodrug Laromustine inhibits angiogenesis in vitro by inducing ASK1-dependent endothelial cell death Cancer Research. 71: 4469-4469. DOI: 10.1158/1538-7445.Am2011-4469 |
0.487 |
|
| 2010 |
Paine AN, Praggastis VA, Dale LE, Tepper JL, Reichelderfer B, Rice KP. Abstract 3639: Cell death mechanisms associated with the carbamoylating activity of the anticancer prodrug Laromustine Cancer Research. 70: 3639-3639. DOI: 10.1158/1538-7445.Am10-3639 |
0.609 |
|
| 2009 |
Ishiguro K, Rice AM, Rice KP, Sartorelli AC. Inhibition of all-trans retinoic acid-induced granulocytic differentiation of WEHI-3B D+ cells by forced expression of SCL (TAL1) and GATA-1. Leukemia Research. 33: 1249-54. PMID 19230972 DOI: 10.1016/J.Leukres.2009.01.022 |
0.545 |
|
| 2009 |
Frederick AM, Davis ML, Rice KP. Inhibition of human DNA polymerase beta activity by the anticancer prodrug Cloretazine. Biochemical and Biophysical Research Communications. 378: 419-23. PMID 19026985 DOI: 10.1016/J.Bbrc.2008.11.042 |
0.456 |
|
| 2008 |
Lin ZP, Zhu YL, Johnson DR, Rice KP, Nottoli T, Hains BC, McGrath J, Waxman SG, Sartorelli AC. Disruption of cAMP and prostaglandin E2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response. Molecular Pharmacology. 73: 243-51. PMID 17959714 DOI: 10.1124/Mol.107.039594 |
0.525 |
|
| 2005 |
Rice KP, Penketh PG, Shyam K, Sartorelli AC. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU. Biochemical Pharmacology. 69: 1463-72. PMID 15857610 DOI: 10.1016/J.Bcp.2005.02.016 |
0.523 |
|
| 2001 |
Rice KP, Eggler AL, Sung P, Cox MM. DNA pairing and strand exchange by the Escherichia coli RecA and yeast Rad51 proteins without ATP hydrolysis: on the importance of not getting stuck. The Journal of Biological Chemistry. 276: 38570-81. PMID 11504729 DOI: 10.1074/Jbc.M105678200 |
0.679 |
|
| 2000 |
Rice KP, Chaput JC, Cox MM, Switzer C. RecA protein promotes strand exchange with DNA substrates containing isoguanine and 5-methyl isocytosine Biochemistry. 39: 10177-10188. PMID 10956007 DOI: 10.1021/Bi0003339 |
0.589 |
|
| Show low-probability matches. |